Mehmet Cudi Tuncer

Prof. Dr. Mehmet Cudi Tuncer

Department of Anatomy, Dicle University, Diyarbakır, Turkey (Türkiye)
orcid

Research Focus & Metrics

Academic Career Length

22Years (2005-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 January 2008 in World Journal of Gastroenterology
Verified
Journal Article
Open access
EGERCAN GEDIK
ERCAN GEDIK
SGSadullah Girgin
Sadullah Girgin
MAMustafa Aldemir
Mustafa Aldemir
CKCelalettin Keles
Celalettin Keles
Mehmet Cudi TuncerMehmet Cudi Tuncer
Mehmet Cudi Tuncer
AAAyfer Aktas
Ayfer Aktas
Non-traumatic splenic rupture: Report of seven cases and review of the literature

29 January 2005 in Surgical and Radiologic Anatomy
Verified
Journal Article
Closed access
PDF file
Mehmet Cudi TuncerMehmet Cudi Tuncer
Mehmet Cudi Tuncer
EHE. S. Hatipoğlu
E. S. Hatipoğlu
MÖM. Özateş
M. Özateş

7 September 2021 in Folia Morphologica
Verified
Journal Article
Closed access
PDF file
MKM. C. Küba
M. C. Küba
ATA. Türkoğlu
A. Türkoğlu
AOA. Oğuz
A. Oğuz
Mehmet Cudi TuncerMehmet Cudi Tuncer
Mehmet Cudi Tuncer
ŞKŞ. Kaya
Ş. Kaya
FTF. Tatlı
F. Tatlı
We compared the effects of rosmarinic acid and dexpanthenol in a rat experimental wound model. Twenty-four Wistar albino rats weighing 200–250 g were randomly divided into 3 groups. After 2-cm full-thickness skin defects were created, the wounds were washed with sterile 0.9% NaCl solution. After washing, the control group was left untreated, the second group received 5% dexpanthenol cream, and the third group received 10% rosmarinic acid cream. Before excision, the skin was evaluated macroscopically by measuring the reduction in wound size; after excision, histological examination (epithelization, inflammation, fibrosis, granulation) was performed. Macroscopic comparison of the wound sizes showed that group 3 showed a statistically significant difference in wound size reduction compared to the other two groups. Histopathological examination showed that there was no statistically significant difference between the groups. We found that the rosmarinic acid group had greater wound size reduction than the other two groups. However, epithelialization was detected in fewer cases. We believe that rosmarinic acid can be used as a topical cream for wound healing, as it leads to significant reduction in wound size, resulting in fewer scars. We compared the effects of rosmarinic acid and dexpanthenol in a rat experimental wound model. Twenty-four Wistar albino rats weighing 200–250 g were randomly divided into 3 groups. After 2-cm full-thickness skin defects were created, the wounds were washed with sterile 0.9% NaCl solution. After washing, the control group was left untreated, the second group received 5% dexpanthenol cream, and the third group received 10% rosmarinic acid cream. Before excision, the skin was evaluated macroscopically by measuring the reduction in wound size; after excision, histological examination (epithelization, inflammation, fibrosis, granulation) was performed. Macroscopic comparison of the wound sizes showed that group 3 showed a statistically significant difference in wound size reduction compared to the other two groups. Histopathological examination showed that there was no statistically significant difference between the groups. We found that the rosmarinic acid group had greater wound size reduction than the other two groups. However, epithelialization was detected in fewer cases. We believe that rosmarinic acid can be used as a topical cream for wound healing, as it leads to significant reduction in wound size, resulting in fewer scars.

1 September 2006 in Annals of Anatomy - Anatomischer Anzeiger
Verified
Journal Article
Closed access
EHEyüp Savaş Hatipoğlu
Eyüp Savaş Hatipoğlu
PKPiraye Kervancioğlu
Piraye Kervancioğlu
Mehmet Cudi TuncerMehmet Cudi Tuncer
Mehmet Cudi Tuncer

12 September 2008 in International Urology and Nephrology
Verified
Journal Article
Closed access
PDF file
ADAli Ihsan Dokucu
Ali Ihsan Dokucu
HOHulya Ozturk
Hulya Ozturk
HOHayrettin Ozturk
Hayrettin Ozturk
Mehmet Cudi TuncerMehmet Cudi Tuncer
Mehmet Cudi Tuncer
FYFahri Yilmaz
Fahri Yilmaz

2 June 2020 in Folia Morphologica
Verified
Journal Article
Open access
PDF file
AOAbdullah Oğuz
Abdullah Oğuz
ABAbdullah Böyük
Abdullah Böyük
AEAysun Ekinci
Aysun Ekinci
UAUlaş Alabalık
Ulaş Alabalık
ATAhmet Türkoğlu
Ahmet Türkoğlu
UAUlaş Aday
Ulaş Aday
Background: To investigate the protective effects of rosmarinic acid in rats exposed to hepatic ischemia/reperfusion injury. Materials and methods: Thirty-two rats were randomly classified into four groups of eight rats each: laparotomy without medication, rosmarinic acid (dose of 50 mg/kg via oral gavage) followed by laparotomy, laparotomy followed by hepatic ischemia/reperfusion, and hepatic ischemia/reperfusion with rosmarinic acid. Serum aspartate aminotransferase, alanine aminotransferase, and malondialdehyde levels and total oxidant activity and total antioxidant capacity levels of the liver, lung, and kidney were assessed. The histopathologic assessment was also performed. Results: Rosmarinic acid significantly reduced liver function test parameters and decreased oxidative stress and abnormal histopathologic findings in the liver. The oxidative stress in the lung significantly increased in the ischemia/reperfusion group but significantly decreased in the ischemia/reperfusion + rosmarinic acid group due to the addition of rosmarinic acid. Rosmarinic acid led to no reduction in oxidative stress in kidney following hepatic ischemia/reperfusion injury. There were no statistically significant differences among the groups regarding histopathologic changes in kidney and lung sections. Conclusions: Rosmarinic acid has antioxidant properties and is an effective hepatoprotective agent. However, although rosmarinic acid provides useful effects in the lung by increasing antioxidant capacity and reducing oxidative stress after ischemia/reperfusion injury, it does not ameliorate histopathologic changes. These findings suggest that rosmarinic acid is likely to provide favorable outcomes in the treatment of hepatic ischemia/reperfusion injury. Background: To investigate the protective effects of rosmarinic acid in rats exposed to hepatic ischemia/reperfusion injury. Materials and methods: Thirty-two rats were randomly classified into four groups of eight rats each: laparotomy without medication, rosmarinic acid (dose of 50 mg/kg via oral gavage) followed by laparotomy, laparotomy followed by hepatic ischemia/reperfusion, and hepatic ischemia/reperfusion with rosmarinic acid. Serum aspartate aminotransferase, alanine aminotransferase, and malondialdehyde levels and total oxidant activity and total antioxidant capacity levels of the liver, lung, and kidney were assessed. The histopathologic assessment was also performed. Results: Rosmarinic acid significantly reduced liver function test parameters and decreased oxidative stress and abnormal histopathologic findings in the liver. The oxidative stress in the lung significantly increased in the ischemia/reperfusion group but significantly decreased in the ischemia/reperfusion + rosmarinic acid group due to the addition of rosmarinic acid. Rosmarinic acid led to no reduction in oxidative stress in kidney following hepatic ischemia/reperfusion injury. There were no statistically significant differences among the groups regarding histopathologic changes in kidney and lung sections. Conclusions: Rosmarinic acid has antioxidant properties and is an effective hepatoprotective agent. However, although rosmarinic acid provides useful effects in the lung by increasing antioxidant capacity and reducing oxidative stress after ischemia/reperfusion injury, it does not ameliorate histopathologic changes. These findings suggest that rosmarinic acid is likely to provide favorable outcomes in the treatment of hepatic ischemia/reperfusion injury.